We synthesized a series of di-, tri- and tetravalent rigid scaffolds (terephthalic acid, trimesic acid and adamantane-1,3,5,7-tetracarboxylic acid) conjugated to c(RGDyK) ligands, which were linked contiguously or separated by the oligo(ethylene glycol) spacers. The inhibition constants of these c(RGDyK) derivatives were determined by competition assays with 125I-labeled echistatin.
While c(RGDyK) function is a relative weak competitor against [125I]echistatin (Ki, 329±18 nM) for αvβ3 integrin-expressing U87MG cells, RGD dimers improved the competition potency considerably (Ki, 64±23 nM). This effect was even more pronounced with the RGD trimers (Ki, 40±7 nM) and tetramers (Ki, 26±9 nM). The introduction of EGn spacers and the increase of linker lengths proved to be detrimental since more competitors were needed to compete with [125I]echistatin. The EG6 group, for example, reduced the inhibition constants by 29 % (dimer), 57 % (trimer) and 97 % (tetramer).
The binding experiments performed with the three forms of multivalent RGD ligands indicate the weakening of competitive potency against [125I]echistatin with the introduction of EGn spacers. This effect may be related to the decrease of the effective RGD molarity, which becomes most prominent within the tetravalent series.